24 results
Disorders of the Hepatic and Mesenteric Circulation

Platelets in Cirrhosis
Hypercoagulability in Cirrhosis
Bleeding in Cirrhosis
Portal Vein Thrombosis (PVT)
Mesenteric
Disorders of the Hepatic ... Bleeding in Cirrhosis ... EmoryGastroHep #Hepatic ... Circulation #Disorders #Hepatology ... #Gastroenterology
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
Beta-Blockers in Cirrhosis ... first variceal bleeding ... #BetaBlockers #Cirrhosis ... #hepatology #management ... #pharmacology #
Management and Complications of Cirrhosis and Ascites

Ascites Workup Algorithm
Ascites Management
Refractory Ascites
Hyponatremia
Spontaneous Bacterial Peritonitis (SBP)
Hepatic Hydrothorax
AKI in
Complications of Cirrhosis ... Peritonitis (SBP) Hepatic ... TinaPhamHang #Cirrhosis ... diagnosis #management #gastroenterology ... #hepatology
Cirrhosis Timeline and Mortality Rate
Compensated Cirrhosis
Stage 1 - No varices (Annual Mortality Rate 1%)
Stage 2 -
Cirrhosis Timeline ... Rate Compensated Cirrhosis ... Stage 4 - Gl bleeding ... or Hepatic Encephalopathy ... Timeline #diagnosis #hepatology
Approach to the Hospitalized Patient with Cirrhosis
1) Recognize and Manage Decompensation
 • Ascites
 • Variceal Bleeding
Hospitalized Patient with Cirrhosis ... Ascites • Variceal Bleeding ... • Hepatic Encephalopathy ... DeanEhrlich_MD #inpatient #Cirrhosis ... #diagnosis #treatment
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
those with CLD (± cirrhosis ... months without treatment ... Liver #Failure #Cirrhosis ... #Hepatology #gastroenterology
Disseminated Intravascular Coagulation (DIC) Overview

Increased Clotting and Consumption of Clotting Factors

Findings:
 • Bleeding
 • Recent history
dysfunction (25%) • Hepatic ... Treatment: ... 100mg/dL) - Heparin ... diagnosis #causes #treatment ... #management #hematology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... small amount of hepatic ... Hemoptysis, GI Bleeding ... #Indications #Pharmacology ... #hematology
Preventing Decompensation in Cirrhosis 

cACLD, CSPH, and the Rule of Five
Prevention of Decompensation
Nonselective Beta Blockers (NSBB)
Preventing
Decompensation in Cirrhosis ... Preventing recurrent bleeding ... #Prevention #treatment ... #management #hepatology ... #gastroenterology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
at high risk of bleeding ... interactions and bleeding ... recurrent VTE and bleeding ... low-molecular-weight heparin ... Anticoagulation #Management #Hematology